ESC Premium Access

Non-invasive risk prediction based on right ventricular function in patients with pulmonary arterial hypertension

Presentation

About the speaker

Mrs Vazhma Qaderi

The University Medical Center Hamburg-Eppendorf, Hamburg (Germany)
0 follower

4 more presentations in this session

Inclusion of echocardiographic measure of right ventricular function in the non-invasive French pulmonary arterial hypertension risk stratification method

Speaker: Doctor C. Fauvel (Rouen, FR)

Thumbnail

Twenty-year experience and outcomes in a national paediatric pulmonary hypertension service

Speaker: Doctor A. Constantine (London, GB)

Thumbnail

Safety, tolerability, and pharmacokinetics (PK) of treprostinil palmitil inhalation powder (TPIP): a phase 1, randomised, double-blind, single- and multiple-dose study

Speaker: Doctor F. Ismat (Bridgewater, US)

Thumbnail

Treatment effect of selexipag on time to disease progression when initiated early in pulmonary arterial hypertension (PAH) patients: GRIPHON and TRITON pooled analysis

Speaker: Doctor J. Coghlan (London, GB)

Thumbnail

Access the full session

Pulmonary arterial hypertension: risk stratification guides for new treatments and informed outcomes

Speakers: Mrs V. Qaderi, Doctor C. Fauvel, Doctor A. Constantine, Doctor F. Ismat, Doctor J. Coghlan
Thumbnail

About the event

Image

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Related content

ESC Premium Access

Artificial intelligence revolution: opportunities and challenges.

23 October 2021

ESC Premium Access

Demystifying artificial intelligence.

23 October 2021

ESC Premium Access

Heart failure as a complication of covid-19 infection: systematic review and meta-analysis

27 August 2021

This platform is supported by

logo Novo Nordisk